SOLIGENIX INC (SNGX:NASDAQ)
$1.12 -0.02 (-1.7544%)
Analysed SOLIGENIX INC (SNGX:NASDAQ) News Sources
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
10-04-2026
yahoo.com
SNGX: Interim Analysis for Phase 3 CTCL Study in 2Q26
06-04-2026
yahoo.com
Soligenix (SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy
02-04-2026
yahoo.com
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
02-04-2026
yahoo.com
Soligenix (SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results
01-04-2026
yahoo.com
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
31-03-2026
yahoo.com
Soligenix (SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behcet Disease
26-03-2026
yahoo.com
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
26-03-2026
yahoo.com
Soligenix (SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach
25-03-2026
yahoo.com
Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting
24-03-2026
yahoo.com
What is the current price of SOLIGENIX INC (SNGX:NASDAQ)?
The current price of SOLIGENIX INC (SNGX:NASDAQ) is $1.12.
SOLIGENIX INC (SNGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SOLIGENIX INC (SNGX:NASDAQ) since the previous trading day is $-0.02.
SOLIGENIX INC (SNGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SOLIGENIX INC (SNGX:NASDAQ) since the previous trading day is -1.7544%.
What is the most recent average sentiment score for SOLIGENIX INC (SNGX:NASDAQ)?
The most recent average sentiment score for SOLIGENIX INC (SNGX:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for SOLIGENIX INC (SNGX:NASDAQ)?
The most recent sentiment for SOLIGENIX INC (SNGX:NASDAQ) is .
SEC-8K** Filing Available For SOLIGENIX INC (SNGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.